We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
CytomX Therapeutics
CTMX
$705M
| $611K | ﹤0.01% |
21,472
-3,534
| -14% | -$101K |
|
1027
Toro Company
TTC
$8.93B
| $610K | ﹤0.01% |
9,768
-313
| -3% | -$19.9K |
|
|
ZEN
1028
DELISTED
ZENDESK INC
ZEN
| $610K | ﹤0.01% |
12,746
-2,058
| -14% | -$85.3K |
|
1029
Teledyne Technologies
TDY
$30.4B
| $609K | ﹤0.01% |
3,255
-82
| -2% | -$15.5K |
|
1030
Hubbell
HUBB
$25.7B
| $608K | ﹤0.01% |
4,995
-160
| -3% | -$21K |
|
1031
NewMarket
NEU
$7.17B
| $606K | ﹤0.01% |
1,508
-1
| -0.1% | -$407 |
|
1032
Carpenter Technology
CRS
$30B
| $603K | ﹤0.01% |
13,662
-889
| -6% | -$44.8K |
|
1033
FirstCash
FCFS
$8.55B
| $599K | ﹤0.01% |
7,371
-948
| -11% | -$70.7K |
|
1034
Commault Systems
CVLT
$5.89B
| $597K | ﹤0.01% |
10,444
-990
| -9% | -$53.4K |
|
1035
Four Corners Property Trust
FCPT
$2.86B
| $591K | ﹤0.01% |
25,589
-1,543
| -6% | -$35.5K |
|
1036
TherapeuticsMD
TXMD
$23.8M
| $590K | ﹤0.01% |
2,425
-399
| -14% | -$112K |
|
1037
Patterson-UTI
PTEN
$3.87B
| $589K | ﹤0.01% |
33,615
-1,947
| -5% | -$40.6K |
|
1038
JetBlue
JBLU
$1.96B
| $587K | ﹤0.01% |
28,892
-291
| -1% | -$6.19K |
|
|
WPG
1039
DELISTED
Washington Prime Group Inc.
WPG
| $586K | ﹤0.01% |
9,765
-569
| -6% | -$33.3K |
|
1040
SITE Centers
SITC
$230M
| $583K | ﹤0.01% |
61,685
-1,042
| -2% | -$10.5K |
|
|
GHDX
1041
DELISTED
Genomic Health, Inc.
GHDX
| $583K | ﹤0.01% |
18,641
-3,033
| -14% | -$101K |
|
|
MDRX
1042
DELISTED
Veradigm Inc. Common Stock
MDRX
| $580K | ﹤0.01% |
46,941
-3,399
| -7% | -$48.3K |
|
1043
Pediatrix Medical
MD
$2.16B
| $577K | ﹤0.01% |
10,371
-304
| -3% | -$16.7K |
|
1044
PBF Energy
PBF
$7.29B
| $572K | ﹤0.01% |
16,875
-1,015
| -6% | -$32.8K |
|
|
BOLD
1045
DELISTED
Audentes Therapeutics, Inc
BOLD
| $572K | ﹤0.01% |
19,029
+508
| +3% | +$17.2K |
|
1046
WEX
WEX
$6.11B
| $571K | ﹤0.01% |
3,648
-85
| -2% | -$12.8K |
|
1047
Cabot Corp
CBT
$4.65B
| $567K | ﹤0.01% |
10,180
+57
| +0.6% | +$3.6K |
|
|
CPE
1048
DELISTED
Callon Petroleum Company
CPE
| $567K | ﹤0.01% |
4,280
-456
| -10% | -$53.5K |
|
|
LMNX
1049
DELISTED
Luminex Corp
LMNX
| $567K | ﹤0.01% |
26,890
-4,147
| -13% | -$84.7K |
|
|
JBTM
1050
JBT Marel
JBTM
$7.14B
| $566K | ﹤0.01% |
4,993
-630
| -11% | -$72.1K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.